UGM-IN-1

Overview

UGM-IN-1 (compound 107) is a selective competitive inhibitor of Mycobacterium tuberculosis UDP-Galp mutase (UGM) , encoded by Rv3809c . UGM-IN-1 inhibits the conversion of UDP-galactopyranose ( UDP-Galp ) to UDP-galactofuranose ( UDP-Galf ), thereby blocking the synthesis of key components of the mycobacterial cell wall, including mycolic acid-arabinogalactan ( mAG ) and liparabinomannan ( LAM ), leading to anti-mycobacterial activity against Mycobacterium tuberculosis . UGM-IN-1 is useful for research on tuberculosis, including drug-resistant tuberculosis .

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Bacterial Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > Bacterial

Product Information

• Catalog No.: HY-180407
• CAS No.: 1027102-50-6
• Molecular Formula: C18H13Cl2IN2O2S
• Molecular Weight: 519.18
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source